Non-interventional post-authorization multi-database safety study to assess the risk of myotoxicity, hepatotoxicity and acute pancreatitis in statin-exposed heart failure patients with or without concomitant use of sacubitril/valsartan (Entresto®) First published 31/03/2017 Last updated 11/07/2025 EU PAS number:EUPAS18358 Study Finalised